Mahmoud M AMER, Doaa A. RASHWAN, Maha A SHAKER

Comparative Study of two Doses of Intrathecal Dexmedetomidine Versus Fentanyl as Adjuvant to Hyperbaric Bupivacaine Spinal Anesthesia

The aim of this study was to evaluate the effect of addition two different doses of dexmedetomidine or fentanyl to intrathecal hyperbaric bupivacaine on spinal block characteristics, intraoperative hemodynamics, the blood glucose level and postoperative pain. 100 patients ASA I and II, ages 20 -60 years old undergoing elective surgeries below the umbilicus under spinal anesthesia were divided into four groups (n=25 each): Patients were randomly allocated into four equal groups (n= 25, each): Group I: received 3 mL of 0.5% hyperbaric bupivacaine +0.5ml normal saline. Group II: received 3 mL of 0.5% hyperbaric bupivacaine plus 3 μg dexmedetomidine (diluted in 0.5ml of normal saline) intrathecal. Group III: received 3 mL of 0.5% hyperbaric bupivacaine plus 5 μg dexmedetomidine (diluted in 0.5ml of normal saline) intrathecal. Group IV: received 3 mL of 0.5% hyperbaric bupivacaine plus 25 μg fentanyl (0.5ml) intrathecal. intraoperative heart rate and mean arterial blood pressure showed no statistical significant differences between the study groups, patients in group II, III and IV had significantly longer sensory and motor block times than patients in group I. The time of first request of postoperative analgesia was statistically significantly shorter in group I compared to the other groups. Pain scores were higher in group I compared to the other groups. Postoperative blood glucose level was only statistically significantly higher in group II compared to the other groups. Both intrathecal dexmedetomidine and fentanyl are associated with prolongation of sensory and motor block, with stable hemodynamics, minimal effect on blood glucose level, and better postoperative analgesia, compared to intrathecal bupivacaine alone

PDF

___

1. Mahendru V, Tewari A, Katyal S, Grewal A, Singh MR, Katyal R. A comparison of intrathecal dexmedetomidine, clonidine, and fentanyl as adjuvants to hyperbaric bupivacaine for lower limb surgery: A double blind controlled study. J Anaesthesiol Clin Pharmacol. 2013;29(4):496-502.

2. Gupta M, Shailaja S, Hegde KS. Comparison of intrathecal dexmedetomidine with buprenorphine as adjuvant to bupivacaine in spinal asnaesthesia. J Clin Diagn Res. 2014;8(2):114-7.

3. Brown DL. Spinal, epidural and caudal anesthesia. in: Miller RD Anesthesia. Philadelphia, Pa: Churchili Livingstone 2000; L4g2-8.

4. Sherif AA, El-lakany MH. Intrathecal dexmedetomidine: Useful or not? J Anesth Clin Res. 2013,4:9

5. Eid HEA, Shafie MA, Youssef H. Dose-related prolongation of hyperbaric bupivacaine spinal anesthesia by dexmedetomidine. Ain Shams Journal of Anesthesiology. 2011;4(2):83-95.

6. Gupta R, Verma R, Bogra J, Kohli M, Raman R, Kushwaha JK. A Comparative study of intrathecal dexmedetomidine and fentanyl as adjuvants to Bupivacaine. J Anaesthesiol Clin Pharmacol. 2011;27(3):339‑43.

7. Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, AlYaman R, Bulbul M, Baraka AS. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand. 2006;50(2):222-7.

8. Kalso E, Poyhia R, Rosenberg P. Spinal antinociception by dexmedetomidine, a highly selective a2-adrenergic agonist. Pharmacol Toxicol. 1991;68(2):140-3.

9. Asano T, Dohi S, Ohta S, Shimonaka H, Lida H. Antinociception by epidural and systemic alpha 2 adrenoreceptor agonists and their binding affinity in rat spinal cord and brain. Anesth Analg. 2000;90(2):400-7.

10. Shah A, Patel I, Gandhi R. Haemodynamic effects of intrathecal dexmedetomidine added to ropivacaine intraoperatively and for postoperative analgesia. Int J Basic Clin Pharmacol. 2013;2(1):26-9.

11. Eisenach JC, De Kock M, Klimscha W. Alpha(2)-adrenergic agonists for regional anesthesia. A clinical review of clonidine (1984-1995). Anesthesiology.1996;85(3):655-74.

12. Mukhtar AM, Obayah EM, Hassona AM. The use of dexmedetomidine in pediatric cardiac surgery. AnesthAnalg. 2006;103(1):52-6.

13. Bromage PR. A comparison of the hydrochloride and carbon dioxide salts of lidocaine and prilocaine in epidural analgesia. Acta Anaesthesiol Scand.1965;16:55-69.

14. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxolone-alphadalone. Br Med J. 1974;2(5920):656-9.

15. Kim JE,KimNY,LeeHS,Kil HK. Effects of intrathecal dexmedetomidine on low-dose bupivacaine spinal anesthesia in elderly patients undergoing transurethral prostatectomy. Biol Pharm Bull. 2013;36(6):959-65.

16. Singh R, ShuklaA. Randomized, controlled study to compare the effect of intrathecal clonidine and dexmedetomidine on sensory analgesia and motor block of hyperbaric bupivacaine. JLS. 2012;2(4):24-33.

17. Niu XY, Ding XB, Guo T, Chen MH, Fu SK, Li Q. Effects of intravenous and Intrathecal dexmedetomidine in spinal anesthesia: a meta-analysis. CNS Neurosci Ther. 2013;19(11):897-904.

18. Bulow NM, Barbosa NV, Rocha JB. Opioid consumption in total intravenous anesthesia is reduced with dexmedetomidine: a comparative study with remifentanil in gynecologic video laparoscopic surgery. J Clin Anesth. 2007;19(4):280-5.

19. Venn RM, Bryant A, Hall GM, Grounds RM. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth. 2001; 86(5):650-6.

20. Pypendop BH, Barter LS, Stanley SD, Ilkiw JE. Hemodynamic effects of dexmedetomidine in isoflurane-anesthetized cats. Vet Anaesth Analg. 2011;38(6):555- 67.